{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-095236","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.438400+00:00","generated_at":"2026-05-31T06:49:31.026994+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"HOOKIPA Pharma: two directors resign; Julie O'Neill appointed Non-Executive Chair","bullets":["Jan van de Winkel and Tim Reilly resign effective Aug 30, 2024, citing increased time commitments from other roles.","Julie O'Neill appointed Non-Executive Chair; Board reduced from 6 to 5 members.","Board reclassified into three classes; O'Neill reappointed as Class I director, term expiring at 2026 Annual Meeting.","Audit Committee: Cassidy (Chair), Kaufman, O'Neill; Compensation: O'Neill (Chair), Cassidy; Nominating: Kaufman (Chair), Cassidy.","Resignations not due to any disagreement with Company's operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-095236","json":"https://secwatch.observer/filing/0001104659-24-095236.json","markdown":"https://secwatch.observer/filing/0001104659-24-095236.md","text":"https://secwatch.observer/filing/0001104659-24-095236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/tm2423083d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:49:31.026994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0febfd009e","claim":"Julie O'Neill was appointed as non-executive chair at HOOKIPA Pharma Inc..","evidence_excerpt":"the Company’s board of directors (the “Board”) appointed Julie O’Neill to serve as non-executive chair of the Board, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"non-executive chair"}],"fact_type":"executive_change"},{"claim_id":"400c6ec2e3","claim":"Jan van de Winkel resigned as director at HOOKIPA Pharma Inc..","evidence_excerpt":"On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"c02622ea4b","claim":"Timothy Reilly resigned as director at HOOKIPA Pharma Inc..","evidence_excerpt":"On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}